Version: 1.0.0 | Published: 21 Jul 2026 | Updated: 50 days ago
Documentation
Associated Media:
Description:
A cross-sectional, prospective pilot study to evaluate the effectiveness of a Thyroid Cancer Patient Decision Aid (PDA TC). PDA-TC is an education pamphlet that assists patients with low-risk thyroid cancer in deciding treatment options between active surveillance, thyroid lobectomy (removal of one thyroid lobe that contains the cancer) or total thyroidectomy (removal of both thyroid lobes), by providing information about the treatment options and their outcomes and by clarifying personal values.
Coverage
Spatial:
United Kingdom
Typical Age Range:
18-150
Follow Up:
6 - 12 Months
Pathway:
Potential participants identified from the Thyroid MDT lists at the respective
study centres by the local head and neck surgical team (patient"s direct care
team). Participants with newly diagnosed low-risk DTC attend two outpatient
clinical appointments as part of their standard thyroid cancer care pathway. In
the initial consultation, thyroid cancer clinicians discuss with participant the
available treatment options (i.e. total thyroidectomy and hemithyroidectomy) for
the low-risk DTC and their associated risks and benefits. Participants allowed a
week to digest the information and to consider the options. In the PDA arm, the
PDA-TC pamphlet introduced to participant after the first outpatient clinical
consultation, in the control arm the pamphlet not provided. A week later,
participants return for the second outpatient consultation where they decide on
the treatment with their clinicians. Participants asked to complete the
Decisional Conflict Scale questionnaire after each consultation in both study
arms. Participants also complete a Satisfaction with Decision Scale
questionnaire and a Preparation for Decision Making Scale questionnaire after
the second consultation in both arms.
Provenance
Origin
Purposes:
Study
Sources:
Other
Collection Situations:
Cohort, study, trial
Temporal
Accrual Periodicity:
Static
Start Date:
19 June 2024
End Date:
22 July 2025
Time Lag:
Not applicable
Accessibility
Access
Access Rights:
in progress
Access Service:
Although not required, there is an option to use The Royal Marsden’s Trusted
Research Environment and informatics platform: BRIDgE (Biomedical Research
Informatics Digital Environment). BRIDgE is managed by The Royal Marsden’s
Information Team with support by the NIHR Biomedical Research Centre at The
Royal Marsden and ICR. The aim of the platform is to transform clinical practice
and improve outcomes for patients by enabling researchers to access real-world
cancer data within secure, collaborative, cloud-based workspaces. Learn more by
visiting the BRIDgE site within the NIHR BRC area of The Royal Marsden and ICR
website: https://www.cancerbrc.org/BRIDgE
Access Request Cost:
Depends on type of access. Costing available on application.
Delivery Lead Time:
Variable
Jurisdictions:
UK
Data Controller:
Royal Marsden NHS Foundation Trust
Data Processor:
Royal Marsden NHS Foundation Trust
Usage
Data Use Limitations:
Research-specific restrictions
Data Use Requirements:
Institution-specific restrictions
Resource Creators:
The Royal Marsden NHS Foundation Trust; NIHR Biomedical Research Centre at The Royal Marsden and the ICR
Format and Standards
Vocabulary Encoding Schemes:
LOCAL
Conforms To:
LOCAL
Languages:
en